Works matching Busulfan

Results: 2023
    1
    2
    3
    4
    5

    Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 304, doi. 10.4143/crt.2022.004
    By:
    • Kyoung Ha Kim;
    • Jae Hoon Lee;
    • Mark Lee;
    • Hoon-Gu Kim;
    • Young Rok Do;
    • Yong Park;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Seog Kim;
    • Seong Kyu Park;
    • Jee Hyun Kong;
    • Moo-Rim Park;
    • Deok-Hwan Yang;
    • Jae-Yong Kwak;
    • Hye Jin Kang;
    • Yeung-Chul Mun;
    • Jong-Ho Won
    Publication type:
    Article
    6
    7
    8
    9

    Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

    Published in:
    Cancer (0008543X), 2017, v. 123, n. 5, p. 824, doi. 10.1002/cncr.30400
    By:
    • Gorin, Norbert‐Claude;
    • Labopin, Myriam;
    • Czerw, Tomasz;
    • Pabst, Thomas;
    • Blaise, Didier;
    • Dumas, Pierre‐Yves;
    • Nemet, Damir;
    • Arcese, William;
    • Trisolini, Silvia Maria;
    • Wu, Depei;
    • Huynh, Anne;
    • Zuckerman, Tsila;
    • Meijer, Ellen;
    • Cagirgan, Seckin;
    • Cornelissen, Jan;
    • Houhou, Mohamed;
    • Polge, Emmanuelle;
    • Mohty, Mohamad;
    • Nagler, Arnon
    Publication type:
    Article
    10
    11

    Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 3, p. 651, doi. 10.1007/s00277-023-05084-x
    By:
    • Kamijo, Kimimori;
    • Shimomura, Yoshimitsu;
    • Shinohara, Akihito;
    • Mizuno, Shohei;
    • Kanaya, Minoru;
    • Usui, Yoshiaki;
    • Kim, Sung-Won;
    • Ara, Takahide;
    • Mizuno, Ishikazu;
    • Kuriyama, Takuro;
    • Nakazawa, Hideyuki;
    • Matsuoka, Ken-ichi;
    • Kusumoto, Shigeru;
    • Maseki, Nobuo;
    • Yamaguchi, Masaki;
    • Ashida, Takashi;
    • Onizuka, Makoto;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Kondo, Eisei
    Publication type:
    Article
    12
    13
    14
    15

    Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid Diseases.

    Published in:
    Cancers, 2025, v. 17, n. 7, p. 1140, doi. 10.3390/cancers17071140
    By:
    • Suh, Hyung C.;
    • Rowley, Scott D.;
    • Kaur, Sukhdeep;
    • Lukasik, Brittany;
    • McKiernan, Phyllis;
    • Boonstra, Michele;
    • Baker, Melissa;
    • DiLorenzo, Mary;
    • Skarbnik, Alan;
    • Voss, Jason;
    • Hampson, Alexandra;
    • DeAgresta, Bianca;
    • Boylan, Brighid;
    • Nyirenda, Themba;
    • Vesole, David H.;
    • Donato, Michele L.
    Publication type:
    Article
    16

    Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2789, doi. 10.3390/cancers13112789
    By:
    • Abate, Massimo E.;
    • Cammelli, Silvia;
    • Ronchi, Letizia;
    • Diletto, Barbara;
    • Gandola, Lorenza;
    • Paioli, Anna;
    • Longhi, Alessandra;
    • Palmerini, Emanuela;
    • Puma, Nadia;
    • Tamburini, Angela;
    • Mascarin, Maurizio;
    • Coassin, Elisa;
    • Prete, Arcangelo;
    • Asaftei, Sebastian D.;
    • Manzitti, Carla;
    • Bisogno, Gianni;
    • Pierobon, Marta;
    • Coccoli, Luca;
    • Capasso, Mariella;
    • Grignani, Giovanni
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 3, p. 666, doi. 10.3109/10428194.2015.1071488
    By:
    • Lombardi, Lindsey R.;
    • Kanakry, Christopher G.;
    • Zahurak, Marianna;
    • Durakovic, Nadira;
    • Bolaños-Meade, Javier;
    • Kasamon, Yvette L.;
    • Gladstone, Douglas E.;
    • Matsui, William;
    • Borrello, Ivan;
    • Huff, Carol Ann;
    • Swinnen, Lode J.;
    • Brodsky, Robert A.;
    • Ambinder, Richard F.;
    • Fuchs, Ephraim J.;
    • Rosner, Gary L.;
    • Jones, Richard J.;
    • Luznik, Leo
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.

    Published in:
    Pediatrics International, 2019, v. 61, n. 6, p. 558, doi. 10.1111/ped.13859
    By:
    • Nishikawa, Takuro;
    • Miyahara, Emiko;
    • Abematsu, Takanari;
    • Nakagawa, Shunsuke;
    • Kodama, Yuichi;
    • Tanabe, Takayuki;
    • Okamoto, Yasuhiro;
    • Kawano, Yoshifumi;
    • Yamaguchi, Hiroki;
    • Nakayama, Kazutaka;
    • Ikawa, Kazuro;
    • Higashi, Erika;
    • Shigemi, Akari;
    • Takeda, Yasuo;
    • Shinkoda, Yuichi
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 12, p. 2037, doi. 10.1007/s00277-014-2152-7
    By:
    • Alvarez-Larrán, Alberto;
    • Martínez-Avilés, Luz;
    • Hernández-Boluda, Juan;
    • Ferrer-Marín, Francisca;
    • Antelo, María;
    • Burgaleta, Carmen;
    • Mata, M.;
    • Xicoy, Blanca;
    • Martínez-Trillos, Alejandra;
    • Gómez-Casares, M.;
    • Durán, M.;
    • Marcote, Bárbara;
    • Ancochea, Agueda;
    • Senín, Alicia;
    • Angona, Anna;
    • Gómez, Montse;
    • Vicente, Vicente;
    • Cervantes, Francisco;
    • Bellosillo, Beatriz;
    • Besses, Carles
    Publication type:
    Article
    41

    Targeted‐dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 773, doi. 10.1002/hon.2789
    By:
    • Esteves, Iracema;
    • Santos, Fabio Pires Souza;
    • Ribeiro, Andreza Alice Feitosa;
    • Seber, Adriana;
    • Sugawara, Eduardo Kinio;
    • Sobrinho, Jairo José do Nascimento;
    • Barros, José Carlos;
    • Oliveira, José Salvador Rodrigues;
    • Fernandes, Juliana Folloni;
    • Hamerschlak, Nelson;
    • Andersson, Borje S.;
    • de Lima, Marcos;
    • Kerbauy, Fabio Rodrigues
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Adipose tissue-derived mesenchymal stem cells repair germinal cells of seminiferous tubules of busulfan-induced azoospermic rats.

    Published in:
    Journal of Human Reproductive Sciences, 2015, v. 8, n. 2, p. 103, doi. 10.4103/0974-1208.158618
    By:
    • Mehrabani, Davood;
    • Hassanshahi, Mohammad Amin;
    • Tamadon, Amin;
    • Zare, Shahrokh;
    • Keshavarz, Saeideh;
    • Rahmanifar, Farhad;
    • Dianatpour, Mehdi;
    • Khodabandeh, Zahra;
    • Jahromi, ImanRazeghian;
    • Tanideh, Nader;
    • Ramzi, Mani;
    • Aqababa, Heydar;
    • Kuhi-Hoseinabadi, Omid
    Publication type:
    Article
    50